Summary
IBM Aspera Faspex contains an incorrect authorization vulnerability that could allow an authenticated user to craft a specific message to bypass authorization, causing privilege escalations.
- Vendor
- IBM
- Product
- Aspera Faspex
- Added to KEV
- Nov 9, 2026
- Remediation due
- Nov 12, 2026 (US federal deadline)
- Ransomware use
- Not known
- Weakness
- CWE-863
- EPSS
- 0.5% as of Nov 12
In the news
- No Asia-Pacific article names this CVE yet.
Linked
Actors named alongside it:
none
Incidents exploiting it:
- none recorded
References